MIT spinout Magnendo lands up to $32M from ARPA-H for autonomous stroke robots
What's the deal? Magnendo, an MIT spinout developing magnetic robotic navigation technology for endovascular intervention, has been selected for an award of up to $32 million from the Advanced Research Projects Agency for Health (ARPA-H)Dealroom has a profile for this one. Try Dealroom → under its Autonomous Interventions and Robotics programme.
Why now? Hundreds of thousands of patients suffer ischaemic strokes caused by large-vessel occlusions each year, yet only a small fraction receive mechanical thrombectomy because the procedure requires highly specialised expertise available at relatively few hospitals.
What it means. The five-year programme will support Magnendo's next-generation magnetic robotic navigation platform, combining robotics, medical imaging and artificial intelligence to enable autonomous endovascular intervention. The company says its preclinical results show improvements in navigation speed and procedural consistency across physicians with varying levels of experience.
Who's saying what? "We believe autonomy will become the next major paradigm shift in endovascular intervention," said founder and CEO Yoonho KimDealroom has a profile for this one. Try Dealroom →.
Read more: AP News
Image credit: Loco Steve
